33 related articles for article (PubMed ID: 28431942)
1. A competent bidrug loaded water soluble chitosan derivative for the effective inhibition of breast cancer.
E A K N; S B; Martin CA; J RR; A S; V N; B S L; Frank-Kamenetskaya OV; Radhakrishnan S; S NK
Sci Rep; 2020 Mar; 10(1):3991. PubMed ID: 32132583
[TBL] [Abstract][Full Text] [Related]
2. Controlled release of 5-fluorouracil and progesterone from magnetic nanoaggregates.
Ragab DM; Rohani S; Consta S
Int J Nanomedicine; 2012; 7():3167-89. PubMed ID: 22802683
[TBL] [Abstract][Full Text] [Related]
3. Pectin-Tannic Acid Nano-Complexes Promote the Delivery and Bioactivity of Drugs in Pancreatic Cancer Cells.
Chauhan SS; Shetty AB; Hatami E; Chowdhury P; Yallapu MM
Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32235765
[TBL] [Abstract][Full Text] [Related]
4. Specific interaction based drug loading strategies.
Yu H; Zhang S; Yang H; Miao J; Ma X; Xiong W; Chen G; Ji T
Nanoscale Horiz; 2023 Oct; 8(11):1523-1528. PubMed ID: 37592921
[TBL] [Abstract][Full Text] [Related]
5. Corrigendum to - Chitosan modified 5-fluorouracil nanostructured lipid carriers for treatment of diabetic retinopathy in rats: A new dimension to an anticancer drug, Vol. 224, 1 January 2023, Pages 810-830.
Sharma DS; Wadhwa S; Gulati M; Kumar B; Chitranshi N; Gupta VK; Alrouji M; Alhajlah S; AlOmeir O; Vishwas S; Khursheed R; Saini S; Kumar A; Parveen SR; Gupta G; Zacconi F; Chellappan DK; Morris A; Loebenberg R; Dua K; Singh SK
Int J Biol Macromol; 2024 Apr; 265(Pt 2):131069. PubMed ID: 38552592
[No Abstract] [Full Text] [Related]
6. Biodynamer Nano-Complexes and -Emulsions for Peptide and Protein Drug Delivery.
Liu Y; Hamm T; Eichinger TR; Kamm W; Wieland HA; Loretz B; Hirsch AKH; Lee S; Lehr CM
Int J Nanomedicine; 2024; 19():4429-4449. PubMed ID: 38784761
[TBL] [Abstract][Full Text] [Related]
7. Development of a Temperature-Responsive Hydrogel Incorporating PVA into NIPAAm for Controllable Drug Release in Skin Regeneration.
Choi JH; Lee JS; Yang DH; Nah H; Min SJ; Lee SY; Yoo JH; Chun HJ; Moon HJ; Hong YK; Heo DN; Kwon IK
ACS Omega; 2023 Nov; 8(46):44076-44085. PubMed ID: 38027389
[TBL] [Abstract][Full Text] [Related]
8. Injectable Hydrogels Based on Cyclodextrin/Cholesterol Inclusion Complexation and Loaded with 5-Fluorouracil/Methotrexate for Breast Cancer Treatment.
Almawash S; Mohammed AM; El Hamd MA; Osman SK
Gels; 2023 Apr; 9(4):. PubMed ID: 37102938
[TBL] [Abstract][Full Text] [Related]
9. Enzyme and Thermo Dual-stimuli Responsive DOX Carrier Based on PNIPAM Conjugated Mesoporous Silica.
Ebrahimi SM; Karamat Iradmousa M; Rashed M; Fattahi Y; Hosseinzadeh Ardakani Y; Bahadorikhalili S; Bafkary R; Erfan M; Dinarvand R; Mahboubi A
Iran J Pharm Res; 2022 Dec; 21(1):e130474. PubMed ID: 36915404
[TBL] [Abstract][Full Text] [Related]
10. Polymerized β-Cyclodextrin-Based Injectable Hydrogel for Sustained Release of 5-Fluorouracil/Methotrexate Mixture in Breast Cancer Management: In Vitro and In Vivo Analytical Validations.
Almawash S; El Hamd MA; Osman SK
Pharmaceutics; 2022 Apr; 14(4):. PubMed ID: 35456651
[TBL] [Abstract][Full Text] [Related]
11. Spray Drying of Chitosan Acid Salts: Process Development, Scaling Up and Physicochemical Material Characterization.
de la Paz N; Fernández M; López O; Garcia C; Nogueira A; Torres L; Turiño W; Heinämäki J
Mar Drugs; 2021 Jun; 19(6):. PubMed ID: 34204083
[TBL] [Abstract][Full Text] [Related]
12. Polydopamine Modified Superparamagnetic Iron Oxide Nanoparticles as Multifunctional Nanocarrier for Targeted Prostate Cancer Treatment.
Singh N; Sallem F; Mirjolet C; Nury T; Sahoo SK; Millot N; Kumar R
Nanomaterials (Basel); 2019 Jan; 9(2):. PubMed ID: 30678236
[TBL] [Abstract][Full Text] [Related]
13. Multifunctional Nanosystem for Targeted and Controlled Delivery of Multiple Chemotherapeutic Agents for the Treatment of Drug-Resistant Breast Cancer.
Lou S; Zhao Z; Dezort M; Lohneis T; Zhang C
ACS Omega; 2018 Aug; 3(8):9210-9219. PubMed ID: 30197996
[TBL] [Abstract][Full Text] [Related]
14. Chitosan-based nanocomplexes for simultaneous loading, burst reduction and controlled release of doxorubicin and 5-fluorouracil.
Di Martino A; Kucharczyk P; Capakova Z; Humpolicek P; Sedlarik V
Int J Biol Macromol; 2017 Sep; 102():613-624. PubMed ID: 28431942
[TBL] [Abstract][Full Text] [Related]
15. Polysaccharide-based nanocomplexes for co-encapsulation and controlled release of 5-Fluorouracil and Temozolomide.
Di Martino A; Pavelkova A; Maciulyte S; Budriene S; Sedlarik V
Eur J Pharm Sci; 2016 Sep; 92():276-86. PubMed ID: 27154260
[TBL] [Abstract][Full Text] [Related]
16. Amphiphilic chitosan-grafted-functionalized polylactic acid based nanoparticles as a delivery system for doxorubicin and temozolomide co-therapy.
Di Martino A; Sedlarik V
Int J Pharm; 2014 Oct; 474(1-2):134-45. PubMed ID: 25124059
[TBL] [Abstract][Full Text] [Related]
17. Chitosan grafted low molecular weight polylactic acid for protein encapsulation and burst effect reduction.
Di Martino A; Kucharczyk P; Zednik J; Sedlarik V
Int J Pharm; 2015 Dec; 496(2):912-21. PubMed ID: 26453778
[TBL] [Abstract][Full Text] [Related]
18. Hydrophobic amino acids grafted onto chitosan: a novel amphiphilic chitosan nanocarrier for hydrophobic drugs.
Motiei M; Kashanian S; Taherpour AA
Drug Dev Ind Pharm; 2017 Jan; 43(1):1-11. PubMed ID: 27802776
[TBL] [Abstract][Full Text] [Related]
19. Chitosan-based delivery systems for plants: A brief overview of recent advances and future directions.
Mujtaba M; Khawar KM; Camara MC; Carvalho LB; Fraceto LF; Morsi RE; Elsabee MZ; Kaya M; Labidi J; Ullah H; Wang D
Int J Biol Macromol; 2020 Jul; 154():683-697. PubMed ID: 32194112
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
